Skip to content
10-Q

Quarterly Report

MOMENTA PHARMACEUTICALS INC

0001235010-20-000017

← back to feed
Filed
Aug 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 3, 2020 118.85M sh
Capex Q2 2020 · Jun 30, 2020 $1.73M
Capex Q2 2020 · Jun 30, 2019 $1.06M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$105.69M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$111.26M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $191.12M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $382.52M
Stockholders Equity Q2 2020 · Jun 30, 2020 $395.32M
Stockholders Equity Q2 2020 · Mar 31, 2020 $428.19M
Stockholders Equity Q2 2020 · Dec 31, 2019 $454.46M
Stockholders Equity Q2 2020 · Jun 30, 2019 $312.72M
Stockholders Equity Q2 2020 · Mar 31, 2019 $422.56M
Stockholders Equity Q2 2020 · Dec 31, 2018 $461.01M
Current Liabilities Q2 2020 · Jun 30, 2020 $71.73M
Current Liabilities Q2 2020 · Dec 31, 2019 $106.1M
Total Liabilities Q2 2020 · Jun 30, 2020 $127.96M
Total Liabilities Q2 2020 · Dec 31, 2019 $163.91M
Current Assets Q2 2020 · Jun 30, 2020 $457.37M
Current Assets Q2 2020 · Dec 31, 2019 $539.13M
Total Assets Q2 2020 · Jun 30, 2020 $523.28M
Total Assets Q2 2020 · Dec 31, 2019 $618.37M
Sga Expense Q2 2020 · Jun 30, 2020 $25.34M
Sga Expense Q2 2020 · Jun 30, 2020 $39.9M
Sga Expense Q2 2020 · Jun 30, 2019 $46.61M
Sga Expense Q2 2020 · Jun 30, 2019 $70.82M
Rd Expense Q2 2020 · Jun 30, 2020 $38.84M
Rd Expense Q2 2020 · Jun 30, 2020 $73.05M
Rd Expense Q2 2020 · Jun 30, 2019 $32.13M
Rd Expense Q2 2020 · Jun 30, 2019 $60.1M
Operating Income Q2 2020 · Jun 30, 2020 −$57.38M
Operating Income Q2 2020 · Jun 30, 2020 −$98.05M
Operating Income Q2 2020 · Jun 30, 2019 −$116.63M
Operating Income Q2 2020 · Jun 30, 2019 −$164.72M
Revenue Q2 2020 · Jun 30, 2020 $6.61M
Revenue Q2 2020 · Jun 30, 2020 $15.5M
Revenue Q2 2020 · Jun 30, 2019 $5.18M
Revenue Q2 2020 · Jun 30, 2019 $9.3M